Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04578925 · ClinicalTrials.gov registry record · NA

Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents

A NA study, sponsored by OhioHealth.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT04578925: Completed NA study, sponsored by OhioHealth.

NCT04578925 is a NA study that has completed, run by OhioHealth. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04578925, a NA study, has completed, sponsored by OhioHealth.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

The purpose of this study is to test if a mobile device delivered intervention program can improve breast-feeding self-efficacy in primiparous mothers.

Primary Outcome

Breastfeeding self-efficacy scale short form (McCarter-Spaulding \& Dennis, 2010)- The Breastfeeding self-efficacy scale short form (BSES-SF) will be used to measure breastfeeding self-efficacy. The scores for this scale range from 1-5, with higher scores indicating greater self-efficacy related to breastfeeding.

Interventions

  • BEHAVIORAL Happy, Healthy, Loved

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2020-10-01
Est. Completion 2023-03-01
Phase NA
OhioHealth

20 total trials

What the finished NCT04578925 record still lists

NCT04578925 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Happy, Healthy, Loved is the first listed.

NCT04578925 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04578925 about?

NCT04578925 is a clinical study titled "Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents". The purpose of this study is to test if a mobile device delivered intervention program can improve breast-feeding self-efficacy in primiparous mothers.

What is the current status of trial NCT04578925?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2020-10-01. Estimated completion is 2023-03-01.

What interventions are being tested in trial NCT04578925?

The interventions under investigation include: Happy, Healthy, Loved (BEHAVIORAL).

Who is sponsoring clinical trial NCT04578925?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04578925's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04578925, the US trial registry maintained by the National Library of Medicine. NCT04578925 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.